Publication:
HTLV-I antibody screening in donated blood and thalassemic patients.

dc.contributor.authorP. Chiewsilpen_US
dc.contributor.authorW. Iamsilpen_US
dc.contributor.authorP. Hathiraten_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-08-10T08:57:17Z
dc.date.available2018-08-10T08:57:17Z
dc.date.issued1993-10-01en_US
dc.description.abstractThe HTLV-I antibody screening by passive partial agglutination test, Serodia HTLV-I (Fuji-rebio Inc) was performed in a total of 1,225 male and 468 female blood donors from September 1992 to March 1993. In addition, a total of 64 multitransfused thalassemic patients were also studied. All of the sera from donors and patients in both study groups showed no reactive results for HTLV-I antibody. This finding indicated that the HTLV-I infection is not yet a problem in blood transfusion in Thailand. However, the scattered reports of HTLV-I infections from our region should urge the national authority on the surveillance of this infection by epidemiological survey and occasional screening in blood donors.en_US
dc.identifier.citationJournal of the Medical Association of Thailand. Vol.76 Suppl 2, (1993), 103-105en_US
dc.identifier.issn01252208en_US
dc.identifier.other2-s2.0-0027686974en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/22666
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0027686974&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleHTLV-I antibody screening in donated blood and thalassemic patients.en_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0027686974&origin=inwarden_US

Files

Collections